Debt increased 37.4%
Debt changed +37.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$4.8B→$6.6B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →WAB financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 55.3%
Cash & equivalents changed -55.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.5B→$670.0M2 prior comparisons
Operating income increased 27.1%
Operating income changed +27.1% from the comparable as-filed period.
$472.0M→$600.0M3 prior comparisons
Inventory / revenue moved 514 bp lower
Inventory / revenue changed -514 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
95.01%→89.87%3 prior comparisons
Gross margin moved 186 bp higher
Gross margin changed +186 basis points from the comparable as-filed period.
34.66%→36.52%3 prior comparisons
Revenue increased 17.5%
Revenue changed +17.5% from the comparable as-filed period.
$2.7B→$3.2B3 prior comparisons
Research & development increased 40.0%
Research & development changed +40.0% from the comparable as-filed period.
$50.0M→$70.0M3 prior comparisons
Net income increased 17.6%
Net income changed +17.6% from the comparable as-filed period.
$336.0M→$395.0M2 prior comparisons
Operating margin moved 143 bp higher
Operating margin changed +143 basis points from the comparable as-filed period.
17.44%→18.87%3 prior comparisons
Gross profit increased 23.8%
Gross profit changed +23.8% from the comparable as-filed period.
$938.0M→$1.2B3 prior comparisons
Stock-based compensation increased 33.3%
Stock-based compensation changed +33.3% from the comparable as-filed period.
$24.0M→$32.0M3 prior comparisons
Selling, general & administrative increased 15.3%
Selling, general & administrative changed +15.3% from the comparable as-filed period.
$347.0M→$400.0M3 prior comparisons
Inventory increased 11.1%
Inventory changed +11.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.6B→$2.9B4 prior comparisons
SBC / revenue moved 12 bp higher
SBC / revenue changed +12 basis points from the comparable as-filed period.
0.89%→1.01%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.